Title : Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Pub. Date : 1987 Jan 8

PMID : 3537801






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These results demonstrate that recombinant human erythropoietin is effective, can eliminate the need for transfusions with their risks of immunologic sensitization, infection, and iron overload, and can restore the hematocrit to normal in many patients with the anemia of end-stage renal disease. Iron erythropoietin Homo sapiens